Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
11/2004
11/24/2004EP1479779A1 Biological signature of manufactured products
11/24/2004EP1479778A1 Electrochemical sensor with sample pretreatment
11/24/2004EP1479770A1 Surface expression libraries of randomized peptides
11/24/2004EP1479763A2 Mutant luciferase having increased thermostability
11/24/2004EP1479761A1 New enterovirus, vaccines, medicaments and diagnostic kits
11/24/2004EP1479697A1 Tick chitinase
11/24/2004EP1479696A1 Human monoclonal antibody binding Ep-CAM, and its use in cancer therapy
11/24/2004EP1479694A2 Intrabodies ScFv with defined framework that is stable in a reducing environment
11/24/2004EP1479398A1 AGENT CONTROLLING THE APOPTOSIS INDUCTION BY p73
11/24/2004EP1479396A1 Drugs ameliorating circadian rhythum disorder
11/24/2004EP1479027A2 Analysis and management of molecular data and sequences
11/24/2004EP1478928A1 Method of diagnosing adolescent idiopathic scoliosis and related syndromes
11/24/2004EP1478926A1 Ultraphobic surface having a multitude of reversibly producible hydrophilic and/or oleophilic areas
11/24/2004EP1478925A1 Use of ultraphobic surfaces having a multitude of hydrophilic areas for analyzing samples
11/24/2004EP1478911A1 Electrochemical detection of nadh or nadph
11/24/2004EP1478784A2 Method and nucleic acids for the analysis of colorectal cell proliferative disorders
11/24/2004EP1478783A2 Compositions and methods for rolling circle amplification
11/24/2004EP1478782A2 Methods for determining the response of cells to vegf and uses thereof
11/24/2004EP1478781A2 Mononucleotide repeats microsatellite markers for detecting microsatellite instability.
11/24/2004EP1478780A2 Method for in vitro detection of cancers by highlighting allelic imbalances in insertion/deletion markers
11/24/2004EP1478779A1 COMPOUNDS AND PROCESSES FOR SINGLE-POT ATTACHMENT OF A LABEL TO siRNA
11/24/2004EP1478778A2 Method and nucleic acids for the analysis of a colon cell proliferactive disorder
11/24/2004EP1478777A2 Sequences specifically deleted from mycobacterium tuberculosis genome and their use in diagnosistics and as vaccines
11/24/2004EP1478776A2 Method for the qualitative and quantitative determination of genetic material
11/24/2004EP1478775A2 A rapid and sensitive proximity-based assay for the detection and quantification of dna binding proteins
11/24/2004EP1478774A2 Nanoparticles having oligonucleotides attached thereto and uses therefor
11/24/2004EP1478773A2 Methods for assessing and treating leukemia
11/24/2004EP1478772A2 Nucleic acid and amino acid sequences involved in pain
11/24/2004EP1478771A2 Methods for characterization of nucleic acid molecules
11/24/2004EP1478770A2 Screening method for orthopoxvirus antivirals
11/24/2004EP1478769A2 Phytases, nucleic acids encoding them and methods for making and using them
11/24/2004EP1478768A2 Sterility testing apparatus
11/24/2004EP1478767A2 In vitro serological method of diagnosing infective endocarditis
11/24/2004EP1478766A2 Methods for determining the influence of protein binding on antiretroviral activity
11/24/2004EP1478762A2 Nucleic acid-associated proteins
11/24/2004EP1478761A1 Degradation of hydrophobic ester pesticides and toxins
11/24/2004EP1478760A1 Esterases with lipase activity
11/24/2004EP1478758A1 Polymorphisms in elastin, fibrillin, and related genes as predisposing to restenosis and to atherosclerosis
11/24/2004EP1478745A2 Kinases and phosphatases
11/24/2004EP1478739A1 Process for sorting motile particles from lesser-motile particles and apparatus suitable therefor
11/24/2004EP1478733A2 Cold shock inducible expression and production of heterologous polypeptides
11/24/2004EP1478663A1 Novel genes functionally related to dyslexia
11/24/2004EP1478657A2 Sequence analysis of the tetravalent rotavirus vaccine
11/24/2004EP1478395A2 Rapid lateral flow assay for determining exposure to mycobacterium tuberculosis and other mycobacteria
11/24/2004EP1478393A2 Anti-pathogen treatements
11/24/2004EP1478384A2 Method for increasing the survival of dopamine secreting cells
11/24/2004EP1478380A2 Use of tyrosine kinase inhibitors for treating cns disorders
11/24/2004EP1478371A2 Methods and products for enhancing immune responses using imidazoquinoline compounds
11/24/2004EP1407257A4 Microfabricated separation device employing a virtual wall for interfacing fluids
11/24/2004EP1381625B1 Mutants of green fluorescent protein
11/24/2004EP1303539B1 A NOVEL MEMBER OF THE EphA RECEPTOR FAMILY
11/24/2004EP1297177B1 Vibrio bacteria detection and/or differentiation
11/24/2004EP1285085A4 Method of determining thiopurine methyltransferase activity
11/24/2004EP1279038B1 Method of identifying agents that alter the activity of the promoter sequence for crf receptor 2-alpha
11/24/2004EP1277054B1 Electrochemical sensing
11/24/2004EP1276892B1 A bacterial two-hybrid system for protein interaction screening
11/24/2004EP1259635A4 Methods of screening for antimicrobial compounds
11/24/2004EP1238279B1 Helicobacter pylori antigens in blood
11/24/2004EP1224319A4 Diagnostic assays of secreted biological fluids for detection of infection and inflammatory conditions
11/24/2004EP1210464B1 Methods of diagnosing or prognosticating age-related macular degeneration
11/24/2004EP1203090A4 A rapid and sensitive assay for homocysteine
11/24/2004EP1200833B1 Difference detection methods using matched multiple dyes
11/24/2004EP1200470B1 Globular assembly of amyloid beta protein and uses thereof
11/24/2004EP1155325B1 Method for diagnosing and distinguishing stroke
11/24/2004EP1144673A4 Methods of screening protease inhibitors, of inducing mice susceptible to hiv protease inhibitor-induced dyslipidemia, and genes associated therewith
11/24/2004EP1135519A4 Methods and compositions for determining lipid peroxidation levels in oxidant stress syndromes and diseases
11/24/2004EP1115737A4 Novel interferon stimulated and repressed genes
11/24/2004EP1114323B1 Cobalamin assay
11/24/2004EP1100971A4 Wavelength-shifting probes and primers
11/24/2004EP1071695A4 Endotoxin reduction in nucleic acid purification
11/24/2004EP1009827B1 Chimeric binding peptide library screening method
11/24/2004EP1007677B1 Protease-related protein
11/24/2004EP1004021B1 Determining the transforming capability of agents
11/24/2004EP0935679B1 Method for chromosome classification by decorrelation statistical analysis and hardware therefore
11/24/2004EP0920532B1 Detection of differences in nucleic acids
11/24/2004EP0920526B1 Covalent joining of dna strands to rna strands catalyzed by vaccinia topoisomerase
11/24/2004EP0873502B1 Method of isolating cells
11/24/2004EP0856157B1 Tumour-specific p450 protein
11/24/2004EP0811077B1 A rapid test for determining the amount of functionally inactive gene in a gene therapy vector preparation
11/24/2004EP0783317B1 Mimetics of senescent cell derived inhibitors of dna synthesis
11/24/2004EP0745129B1 Non-a, non-b, non-c, non-d, non-e hepatitis reagents and methods for their use
11/24/2004EP0665898B1 Angiotensinogen gene variants and predisposition to hypertension
11/24/2004EP0551438B1 Surface expression libraries of randomized peptides
11/24/2004CN2658158Y Substratum reagent kit for identifying microbe
11/24/2004CN1549864A Evaluating system for predicting cancer return
11/24/2004CN1549857A Testicular carnitine transporter and its gene
11/24/2004CN1549730A Compositions and methods of using capsid protein from flaviviruses and pestiviruses
11/24/2004CN1549721A Alzheimer's disease diagnosis based on mitogen-activated protein kinase phosphorylation
11/24/2004CN1548951A Electro-chemical sensor with sample pretreating function
11/24/2004CN1548945A Biological measuring method for dioxins compound in monitoring environment samples
11/24/2004CN1548557A Reagent kit and primer for predicting susceptibility of type-II diabetes
11/24/2004CN1548556A Reagent kit and primer for predicting susceptibility of type-II diabetes
11/24/2004CN1548555A Reagent kit and primer for predicting susceptibility of type-II diabetes
11/24/2004CN1548554A Reagent kit and primer for predicting susceptibility of type-II diabetes
11/24/2004CN1548553A Reagent kit and primer for predicting susceptibility of type-II diabetes
11/24/2004CN1548552A Detection method and use of susceptible gene of schizophrenia
11/24/2004CN1548551A Design and application in gene diagnosis of peptide nucleic acid molecule beacon probe
11/24/2004CN1548550A Target sequence RT-PCR primer, short-handle ring probe, reagent kit and detection method for SARS related coronavirus distinction and their application
11/24/2004CN1548549A Biochip system based on minute particle and its application
11/24/2004CN1548548A Pre-mixed PCR and RT-PCR reagent containing high-concentration glycerine